Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector-Reference-Cited by-同舟云学术

Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector

Published:2011-11-09 Issue:2 Volume:14 Page:145-159
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:Neuro-Oncology

Author:

Ostertag D.,Amundson K. K.,Lopez Espinoza F.,Martin B.,Buckley T.,da Silva A. P. G.,Lin A. H.,Valenta D. T.,Perez O. D.,Ibanez C. E.,Chen C.-I.,Pettersson P. L.,Burnett R.,Daublebsky V.,Hlavaty J.,Gunzburg W.,Kasahara N.,Gruber H. E.,Jolly D. J.,Robbins J. M.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/14/2/145/6225259/nor199.pdf

Reference46 articles.

1. History of Oncolytic Viruses: Genesis to Genetic Engineering

2. Beyond Oncolytic Virotherapy: Replication-Competent Retrovirus Vectors for Selective and Stable Transduction of Tumors

3. Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of microRNA and suicide gene for targeting Glioblastoma: Inducing apoptosis and significantly suppressing tumor growth in vivo;Heliyon;2024-09

2. Therapeutic activity of retroviral replicating vector-mediated gene therapy in combination with anti-PD-1 antibody in a murine pancreatic cancer model;Cancer Gene Therapy;2024-07-23

3. Modern approaches in suicidal gene therapy of malignant neoplasms;Advances in Molecular Oncology;2024-06-28

4. An Update on the Clinical Status, Challenges, and Future Directions of Oncolytic Virotherapy for Malignant Gliomas;Current Treatment Options in Oncology;2024-06-19

5. Immunotherapeutic Strategies for the Treatment of Glioblastoma: Current Challenges and Future Perspectives;Cancers;2024-03-25